Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

BACKGROUND: Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated influenza vaccine (HD-IIV) are U.S.-licensed for adults aged ≥ 65 years. This study compared serum hemagglutination inhibition (HAI) antibody titers for the A(H3N2) and A(H1N1)pdm09 and B strains after trivalent aI...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmader, Kenneth E., Liu, Christine K., Flannery, Brendan, Rountree, Wes, Auerbach, Heidi, Barnett, Elizabeth D., Schlaudecker, Elizabeth P., Todd, Christopher A., Poniewierski, Marek, Staat, Mary A., Harrington, Theresa, Li, Rongxia, Broder, Karen R., Walter, Emmanuel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314373/
https://www.ncbi.nlm.nih.gov/pubmed/37393237
http://dx.doi.org/10.1186/s12979-023-00355-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314373/
https://www.ncbi.nlm.nih.gov/pubmed/37393237
http://dx.doi.org/10.1186/s12979-023-00355-7

Ejemplares similares